Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Deutsche Lufthansa AG    LHA   DE0008232125

DEUTSCHE LUFTHANSA AG

(LHA)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 10/21 12:20:58 pm
7.825 EUR   -4.81%
10:01aGLOBAL MARKETS LIVE: A flurry of earnings reports
09:04aLUFTHANSA AG : DZ Bank keeps a Sell rating
MD
08:21aLUFTHANSA AG : Independant Research reiterates its Sell rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Lufthansa plans rapid COVID-19 testing starting October - executive

share with twitter share with LinkedIn share with facebook
09/22/2020 | 04:41pm EDT
Lufthansa supervisory board discusses strategy amid the coronavirus pandemic

Deutsche Lufthansa AG plans to start making rapid COVID-19 antigen tests available to passengers in October and is weighing the option of opening test centres at airports in the United States and Canada, a company executive said on Tuesday.

The move comes as airlines and airports globally have urged countries to accept a passenger's negative COVID-19 test as an alternative to travel restrictions and quarantines that have battered demand for travel.

While the aviation industry has largely backed the use of Polymerase Chain Reaction (PCR) tests which take several hours to process in a lab, airline trade group IATA on Tuesday touted antigen tests that can be processed on site and typically give results within about 15 minutes.

Abbott Laboratories recently won the U.S. Food and Drug Administration approval for BinaxNOW, a $5 disposable device the size of a credit card. Some other antigen tests must be read using a small, portable device.

"You know that companies like Abbott or Roche are bringing these tests to the market and we are definitely looking into this," said Bjoern Becker, senior director, product management, ground & digital services for the Lufthansa Group.

"You will see us applying them for new products within the next few weeks in October," he told reporters during a virtual call. "That's definitely the next thing to come."

Becker said Lufthansa is considering making the new antigen tests initially available to its first-class and business class passengers, given limited supply.

Lufthansa is also looking at ways to expand its network of testing centers to airports in the United States and Canada, given that they are important markets, he said.

(Reporting By Allison Lampert in Montreal. Additional reporting by Allison Martell in Toronto)

By Allison Lampert


Stocks mentioned in the article
ChangeLast1st jan.
ABBOTT LABORATORIES -2.05% 106.085 Delayed Quote.24.75%
DEUTSCHE LUFTHANSA AG -4.70% 7.834 Delayed Quote.-49.91%
share with twitter share with LinkedIn share with facebook
All news about DEUTSCHE LUFTHANSA AG
10:01aGLOBAL MARKETS LIVE: A flurry of earnings reports
09:04aLUFTHANSA AG : DZ Bank keeps a Sell rating
MD
08:21aLUFTHANSA AG : Independant Research reiterates its Sell rating
MD
08:11aLUFTHANSA AG : Kepler Cheuvreux reiterates its Sell rating
MD
07:13aLUFTHANSA AG : Deutsche Bank reaffirms its Sell rating
MD
06:12aLUFTHANSA AG : Gets a Sell rating from Morgan Stanley
MD
03:06aLUFTHANSA AG : Bernstein sticks Neutral
MD
10/20LUFTHANSA AG : Goldman Sachs maintains a Sell rating
MD
10/20DEUTSCHE LUFTHANSA : Pandemic-stricken Lufthansa posts 1.26 billion euro third-q..
RE
10/20DEUTSCHE LUFTHANSA : Pandemic-stricken Lufthansa posts 1.26 bln eur Q3 operating..
RE
More news
Financials
Sales 2020 16 487 M 19 573 M 19 573 M
Net income 2020 -5 259 M -6 243 M -6 243 M
Net Debt 2020 12 789 M 15 183 M 15 183 M
P/E ratio 2020 -0,82x
Yield 2020 0,15%
Capitalization 4 913 M 5 812 M 5 833 M
EV / Sales 2020 1,07x
EV / Sales 2021 0,69x
Nbr of Employees 129 356
Free-Float 83,3%
Chart DEUTSCHE LUFTHANSA AG
Duration : Period :
Deutsche Lufthansa AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DEUTSCHE LUFTHANSA AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 22
Average target price 5,63 €
Last Close Price 8,22 €
Spread / Highest target 71,5%
Spread / Average Target -31,6%
Spread / Lowest Target -81,8%
EPS Revisions
Managers
NameTitle
Carsten Spohr Chairman-Executive Board & CEO
Karl-Ludwig Kley Chairman-Supervisory Board
Roland Schütze Chief Information Officer
Christine Behle Deputy Chairman-Supervisory Board
Christina Weber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
DEUTSCHE LUFTHANSA AG-49.91%5 812
DELTA AIR LINES, INC.-45.31%20 312
RYANAIR HOLDINGS PLC-15.24%16 505
AIR CHINA LIMITED-33.75%13 557
CHINA SOUTHERN AIRLINES COMPANY LIMITED-16.98%12 036
UNITED CONTINENTAL HOLDINGS, INC.-59.06%10 493